United States · FDA National Drug Code directory
Maxitrol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82667-100_41ef9a7f-c1aa-de10-e063-6394a90adeec
- Product NDC
- 82667-100
- Form
- SUSPENSION
- Composition / generic term
- neomycin sulfate, polymyxin b sulfate and dexamethasone
- Labeler
- Harrow Eye, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19641115
- Source listing expiry
- 20261231
Source-listed ingredients
- NEOMYCIN SULFATE — 3.5 mg/mL
- POLYMYXIN B SULFATE — 10000 [USP'U]/mL
- DEXAMETHASONE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 BOTTLE, PLASTIC (82667-100-05) · 82667-100-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →